Abstract
Myositis specific autoantibodies (MSAs) are proven to be specific for myositis compared with other inflammatory connective tissue diseases. Their specificity compared, however, with other neuromuscular disorders, which are included in the differential diagnosis of patients in whom the diagnosis myositis is under consideration, is unknown. We prospectively screened sera from 107 patients with various neuromuscular disorders for the most common MSAs and compared the results with the findings in a group of 97 myositis patients, published previously. Special attention was paid to patients with facioscapulohumeral muscular dystrophy (FSHD), an autosomal dominant muscle disease with marked inflammation in skeletal muscle tissue.
Only one patient in the neuromuscular disorders group tested positive for an MSA, compared with 41 in the myositis group, resulting in a specificity of 99%. None of the FSHD patients tested positive. We conclude that the tested MSAs are highly specific for myositis and that they are not merely associated with muscle inflammation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arahata K, Ishihara T, Fukunaga H, Orimo S, Lee JH, Goto K, Nonaka I (1995) Inflammatory response in facioscapulohumeral dystrophy (FSHD): immunocytochemical and genetic analysis. Muscle Nerve 2:S56–S66
Brouwer R, Hengstman GJD, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, Grondal G, Hietarinta M, Isenberg D, Kalden JR, Lundberg I, Moutsopoulos H, Roux–Lombard P, Vencovsky J, Wikman A, Seelig HP, Van Engelen BGM, Van Venrooij WJ (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60:116–123
Brouwer R, Vree Egberts W, Jongen PH, Van Engelen BGM, Van Venrooij WJ (1998) Frequent occurrence of antitRNAHis autoantibodies that recognize a conformational epitope in sera of patients with myositis. Arthritis Rheum 41:1428–1437
Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971–982
Friedman AW, Targoff IN, Arnett FC (1996) Interstitial lung disease with autoantibodies against aminoacyl–tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 26:459–467
Hengstman GJD, Brouwer R, Vree Egberts WTM, Jongen PJH, Seelig HP, Van Venrooij WJ, Van Engelen BGM (2002) Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 249:69–75
Hengstman GJD, Van Engelen BGM, Vree Egberts WTM, Van Venrooij WJ (2001) Myositis specific autoantibodies, overview and recent developments. Curr Opin Rheumatol 13:476–482
Hirakata M, Mimori T, Akizuki M, Craft T, Hardin JA, Homma M (1992) Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 35: 449–456
Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV (2004) Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 50:209–215
Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis–specific autoantibodies define useful homogeneous patient groups. Medicine 70:360–374
Miller FW, Waite KA, Biswas T, Plotz PH (1996) The role of an autoantigen, histidyl–tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci USA 87:9933–9937
Molnár M, Diószeghy P, Mechler F (1991) Inflammatory changes in facioscapulohumeral muscular dystrophy. Eur Arch Psychiatry Clin Neurosci 241:105–108
Perurena O, Targoff IN, Bobele G, Parke J, Husain F (1993) Lack of myositis-specific autoantibodies in Duchenne’s muscular dystrophy. Ann Neurol 34:308
Rutjes SA, Vree Egberts WTM, Jongen P, Van den Hoogen F, Pruijn GJM, Van Venrooij WJ (1997) Anti-Ro52 antibodies frequently co–occur with anti– Jo–1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 109:32–40
Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, Sato T, Kiuchi T, Ohashi Y (1995) Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22:668–674
Vázquez–Abad D, Rothfield NF (1996) Sensitivity and specificity of anti–Jo–1 antibodies in autoimmune diseases with myositis. Arthritis Rheum 39: 292–296
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hengstman, G.J.D., van Brenk, L., Vree Egberts, W.T.M. et al. High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders. J Neurol 252, 534–537 (2005). https://doi.org/10.1007/s00415-005-0683-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0683-5